Table 5.
Adverse reactions of different doses of rhGH in the treatment of ISS (n, %).
| Group | Number of cases | Elevated fasting glucose | Edema | Red and swollen injection site | Rash | Arthrodynia | Total incidence |
|---|---|---|---|---|---|---|---|
| Low-dose group | 59 | 0 | 0 | 0 | 1 | 0 | 1(1.69%) |
| High-dose group | 44 | 1 | 1 | 0 | 0 | 1 | 3(6.82%) |
| χ 2 value | 1.772 | ||||||
| P value | 0.183 |